Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FQ93J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,152
Award facts
- Contract value 100% obligated
- $9,151.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $9,151.52 firm fixed-price delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement that runs through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor with extensive experience fulfilling medical procurement requirements for military and veteran healthcare systems. The company's broad portfolio of federal contract awards encompasses a comprehensive range of therapeutic products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Actemra, a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, reflects the company's ongoing role as a primary supplier of specialized pharmaceuticals to Department of Defense and broader federal healthcare programs through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FQ93J?
SPE2DB25FQ93J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ93J worth?
The government has obligated $9,152 on SPE2DB25FQ93J.
Is contract SPE2DB25FQ93J an order under another contract?
Yes. SPE2DB25FQ93J is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ93J competed?
The extent of competition for SPE2DB25FQ93J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award